143
histology, and immunohistochemistry using a panel of lymphoid
markers (EBV, CD79a, CD20, PAX-5, CD3, and CD30) resulted
in the diagnosis of EBV driven T-cell, B-cell, and Hodgkin-like
LPD. All three patients recovered following cessation of MTX
and surgical debridement.
Although LPD as a cause of ONJ is rare, due to the rise in
immunodeficiency disorders and immunosuppressive treatments,
the prevalence of this condition may be expected to increase. For
this reason, clinicians should be aware of the diagnosis. As this
case series has shown, biopsy and diagnostic immunohistochem-
istry will ensure the correct diagnosis. Because the diagnostic
approach used in this case series will distinguish MTX-related
LPD from the more familiar condition of Medication-related
osteonecrosis of the jaw.
http://dx.doi.org/10.1016/j.ijom.2017.02.493Preventive effect of dental pulp-derived mesenchymal stem
cells in experimental medication-related osteonecrosis of the
jaw
Z.B. Gonen
∗
, S. Bilge, M.E. Onder, O. Etoz, D. Bahar,
A. Alkan
Erciyes University, Kayseri, Turkey
Background:
Medication-related osteonecrosis of the jaw
(MRONJ) has been a complication and the treatment still has been
main challenge of this complication.
Objectives:
The aim of this study was to investigate a prevention
strategy for MRONJ development in rat model.
Methods:
Dental pulp-derived mesenchymal stem cells (DP-
MSCs) were isolated and characterised. Green fluorescent protein
(GFP) was transfected to cells. 40 rats were divided into four
groups (Group 1: tooth extraction; Group 2: tooth extraction after
bisphosphonate therapy; Group 3: DP-MSCs application simul-
taneously with tooth extraction after bisphosphonate therapy;
Group 4: DP-MSCs application one day before of tooth extraction
after bisphosphonate therapy). The bisphosphonate therapy was
0.1 mg/kg zoledronic acid intraperitoneally once per every three
days for 9 weeks. The lower molar tooth of all animals extracted
under general anaesthesia. The animals were sacrificed after six
weeks of healing. Histologic and immunohistochemical analysis
were performed. Expression of osteocalcin, bone morphogenetic
protein 2, and Runt-related transcription factor 2 was assessed by
quantitative polymerase chain reaction analysis.
Findings:
Phenotype characterisation of the DP-MSCs demon-
strated a homogeneous population of cells negative for CD11b,
CD45 and positive for CD44, CD29, CD90, and CD105. The
alveolar sockets were complete (70%) and partial (10%) healed in
group 3 whereas the exposed necrotic bone remained in group
2. Preventive DP-MSCs treatment enhanced the expression of
osteogenic related genes. Immunohistochemical staining showed
the higher staining for those markers and GFP positivity in group
3. Histological analysis showed new bone formation and vascu-
larisation in the DP-MSCs groups.
Conclusion:
Simultaneously DP-MSCs with tooth extraction
showed preventive effects for MRONJ development.
http://dx.doi.org/10.1016/j.ijom.2017.02.494Conservative treatment option for large odontogenic cystic
lesions/tumours — a single centre experience in Karachi,
Pakistan
S.M. Haider
∗
, F. Hameed
Abbassi Shaheed Hospital, Pakistan
Background and Objectives:
Keratocystic odontogenic tumour
(KCOT) is known for its unusual behaviour, different origin,
debatable development, controversial and disputed treatment
modalities. This study aims to present a case series of KCOT
emphasising its solvability without surgical intervention or inva-
sive procedures, and comparing its clinical, radiological and
histopathological characteristics and therapeutic alternatives to
those described in the literature.
Methods:
Our series of 7 patients with histologically proven
KCOTs were treated by marsupialisation surgery from 2003 to
2014. Radiological evaluation done in terms of reduction in lesion
size and, therefore, easy and complete removal become possible
with lower recurrence rate. Patient was followed for years with
radiology and clinical examination to detect recurrence. Good
bone integrity, less morbidity, improved quality of life and better
aesthetics were the primary.
Findings and Conclusions:
KCOT treatment is still debatable
and there is no consensus about it. In our cases bone integrity,
morbidity and functional defect related to surgical intervention
was taken into consideration so that marsupialisation was per-
formed to reduce the tumour size and followed by enucleation
gives good results. Our treatment offers long-term follow-up with
clinical examination and radiology to control the disease.
http://dx.doi.org/10.1016/j.ijom.2017.02.495Vascular malformations of the maxillofacial skeleton — an
overview of presentation and management
A.A. Heggie
∗
, J.M. Shand, A.J. Penington
Oral and Maxillofacial Surgery Unit, Department of Plastic and
Maxillofacial Surgery, Royal Children’s Hospital of Melbourne
and Epworth Hospital, Victoria, Australia
Background:
Vascular disorders of the maxillofacial skeleton
vary from benign localised lesions to aggressive, proliferative
high-flowmalformations that present enormous challenges for the
clinician.
Objectives:
This presentation will describe the classification of
vascular malformations within the maxillofacial complex, their
characteristics and management. The distinction between arteri-
ovenous malformations (AVM) and haemangiomas will also be
highlighted to emphasise that these lesions are separate patholog-
ical entities.
Methods:
A retrospective review of patients (adults and paedi-
atric patients) with a diagnosis of a vascular lesion of the facial
skeleton was undertaken in an attempt to classify the main cate-
gories. The implications for elective and curative surgery were to
be considered and treatment protocols outlined.
Findings:
Of 13 patients with AVM’s, 6 were syndromic low-
flow arteriovenous malformations, 4 were nonsyndromic low-flow
lesions and 3 were high-flow malformations. Sturge-Weber syn-
drome is a phakomatosis due to an embryonal developmental
anomaly (mutations in the GNAQ gene) with several subtypes.




